{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:49:57Z","timestamp":1778705397860,"version":"3.51.4"},"reference-count":220,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.bpa.2012.04.003","type":"journal-article","created":{"date-parts":[[2012,8,19]],"date-time":"2012-08-19T13:03:56Z","timestamp":1345381436000},"page":"179-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Coagulation management in patients undergoing mechanical circulatory support"],"prefix":"10.1016","volume":"26","author":[{"given":"Klaus","family":"G\u00f6rlinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Dirkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"45","key":"10.1016\/j.bpa.2012.04.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9450","article-title":"The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation","volume":"9","author":"Clegg","year":"2005","journal-title":"Health Technol Assess"},{"issue":"48","key":"10.1016\/j.bpa.2012.04.003_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10480","article-title":"Evaluation of the ventricular assist device programme in the UK","volume":"10","author":"Sharples","year":"2006","journal-title":"Health Technol Assess"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.athoracsur.2008.06.030","article-title":"Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy","volume":"86","author":"John","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtcvs.2008.07.032","article-title":"Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices","volume":"137","author":"Crow","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1055\/s-0031-1280746","article-title":"Technical possibilities and limitations of mechanical circulatory support","volume":"46","author":"Krabatsch","year":"2011","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1586\/erd.10.77","article-title":"HeartMate\u00ae II continuous-flow left ventricular assist system","volume":"8","author":"Sheikh","year":"2011","journal-title":"Expert Rev Med Devices"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00398-006-0529-1","article-title":"Coagulation management and mechanical circulatory support: a comparison of different devices","volume":"20","author":"Drews","year":"2006","journal-title":"Z Herz Thorax Gef\u00e4\u00dfchir"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MAT.0b013e3181492929","article-title":"Coagulation management in pediatric mechanical circulatory support","volume":"53","author":"Drews","year":"2007","journal-title":"ASAIO J"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jtcvs.2007.12.077","article-title":"Low thromboembolic risk for patients with the Heartmate II left ventricular assist device","volume":"136","author":"John","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib10","first-page":"569","article-title":"Update on ventricular assist device management in the ICU","volume":"14","author":"Pitsis","year":"2008","journal-title":"Curr Opin Crit Care"},{"issue":"19 Suppl.","key":"10.1016\/j.bpa.2012.04.003_bib11","first-page":"II224","article-title":"Ambulatory care of patients with left ventricular assist devices","volume":"100","author":"Schmid","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0049-3848(00)00323-6","article-title":"Accuracy of a portable prothrombin time monitor (Coagucheck) in patients on chronic oral anticoagulant therapy: a prospective multicenter study","volume":"100","author":"Cosmi","year":"2000","journal-title":"Thromb Res."},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00000542-200102000-00013","article-title":"Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban","volume":"94","author":"Koster","year":"2001","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.bpa.2012.04.003_bib14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0002-9149(03)00159-0","article-title":"Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations","volume":"91","author":"Cho","year":"2003","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib15","first-page":"383","article-title":"Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass","volume":"96","author":"Koster","year":"2003","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/01.CCM.0000055374.77132.4D","article-title":"Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration","volume":"31","author":"Kozek-Langenecker","year":"2003","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jtcvs.2004.06.049","article-title":"Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study","volume":"129","author":"Chung","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1051\/ject\/200537364","article-title":"Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery","volume":"37","author":"Zucker","year":"2005","journal-title":"J Extra Corpor Technol"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib19","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1213\/01.ane.0000205746.50440.98","article-title":"Measurement of patients' bivalirudin plasma levels by a thromboelastograph ecarin clotting time assay: a comparison to a standard activated clotting time","volume":"102","author":"Carroll","year":"2006","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11239-006-4383-5","article-title":"The use of a HEMOCHRON JR. HEMONOX point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures","volume":"21","author":"El Rouby","year":"2006","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.mat.0000249017.91053.af","article-title":"Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device","volume":"52","author":"Ghez","year":"2006","journal-title":"ASAIO J"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/01.mph.0000195296.48319.38","article-title":"Argatroban anticoagulation in pediatric patients: a literature analysis","volume":"28","author":"Hursting","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1345\/aph.1H569","article-title":"Argatroban anticoagulation in critically ill patients","volume":"41","author":"Beiderlinden","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1525-1594.2007.00388.x","article-title":"Argatroban in extracorporeal membrane oxygenation","volume":"31","author":"Beiderlinden","year":"2007","journal-title":"Artif Organs"},{"key":"10.1016\/j.bpa.2012.04.003_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000109642","article-title":"Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis","volume":"34","author":"G\u00f6rlinger","year":"2007","journal-title":"Transfus Med Hemother"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib26","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.athoracsur.2006.11.051","article-title":"Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT","volume":"83","author":"Koster","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1525-1594.2007.00399.x","article-title":"Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants","volume":"31","author":"Meuris","year":"2007","journal-title":"Artif Organs"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/01.ane.0000278868.23814.3b","article-title":"Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin","volume":"105","author":"Tanaka","year":"2007","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00059-008-3130-4","article-title":"Platelet function analysis with point-of-care methods","volume":"33","author":"G\u00f6rlinger","year":"2008","journal-title":"Herz"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1540-8191.2008.00604.x","article-title":"Monitoring of bivalirudin anticoagulation during and after cardiopulmonary bypass using an ecarin-activated TEG system","volume":"23","author":"Koster","year":"2008","journal-title":"J Card Surg"},{"issue":"9","key":"10.1016\/j.bpa.2012.04.003_bib31","first-page":"449","article-title":"A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory","volume":"20","author":"Marmur","year":"2008","journal-title":"J Invasive Cardiol"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ALN.0b013e31817885b7","article-title":"Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin","volume":"109","author":"Molinaro","year":"2008","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib33","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.athoracsur.2008.01.100","article-title":"Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices","volume":"85","author":"Samuels","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1016\/j.bpa.2012.04.003_bib34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1525-1594.2008.00634.x","article-title":"Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation","volume":"32","author":"Sandner","year":"2008","journal-title":"Artif Organs"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-6576.2007.01550.x","article-title":"Rotational thromboelastometry for the bedside monitoring of recombinant hirudin","volume":"52","author":"Sucker","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"issue":"8","key":"10.1016\/j.bpa.2012.04.003_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.healun.2008.05.015","article-title":"Successful treatment of rotary pump thrombus with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"27","author":"Thomas","year":"2008","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib37","first-page":"1181","article-title":"Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma","volume":"100","author":"van den Besselaar","year":"2008","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00059-008-3132-2","article-title":"Interdisciplinary study group \u2013 clinical pharmacology of haemostasis. Methods to evaluate the pharmacology of oral antiplatelet drugs","volume":"33","author":"Weber","year":"2008","journal-title":"Herz"},{"issue":"9","key":"10.1016\/j.bpa.2012.04.003_bib39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.healun.2009.05.018","article-title":"Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation","volume":"28","author":"Boyle","year":"2009","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1160\/TH08-06-0383","article-title":"Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study","volume":"101","author":"Toulon","year":"2009","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.thromres.2010.01.048","article-title":"Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter","volume":"126","author":"Arcangeli","year":"2010","journal-title":"Thromb Res."},{"issue":"16","key":"10.1016\/j.bpa.2012.04.003_bib42","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.jacc.2009.11.080","volume":"55","author":"Gajos","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/09537100903440937","article-title":"Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system","volume":"21","author":"Kobsar","year":"2010","journal-title":"Platelets"},{"issue":"7","key":"10.1016\/j.bpa.2012.04.003_bib44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jacc.2009.08.077","article-title":"Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test","volume":"55","author":"Silvain","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib45","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate \u2013 a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity","volume":"103","author":"van Ryn","year":"2010","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.bpa.2012.04.003_bib46","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1525-1594.2011.01391.x","article-title":"A method for anticoagulation of children on mechanical circulatory support","volume":"35","author":"Copeland","year":"2011","journal-title":"Artif Organs"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib47","first-page":"E63","article-title":"Aortic root and valve thrombosis after implantation of a left ventricular assist device","volume":"23","author":"Freed","year":"2011","journal-title":"J Invasive Cardiol"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/09537104.2010.514967","article-title":"The new INNOVANCE\u00ae PFA P2Y cartridge is sensitive to the detection of P2Y12 receptor inhibition","volume":"22","author":"Koessler","year":"2011","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000329300","article-title":"Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia","volume":"118","author":"Serebruany","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.bpa.2012.04.003_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/j.1525-1594.2011.01403.x","article-title":"Management of single-ventricle patients with berlin heart EXCOR ventricular assist device: single-center experience","author":"Mackling","year":"2012","journal-title":"Artif Organs"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MBC.0b013e32834f1b0c","article-title":"Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran","volume":"23","author":"Stangier","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"8","key":"10.1016\/j.bpa.2012.04.003_bib52","first-page":"879","article-title":"Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol","volume":"30","author":"Pamboukian","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"15","key":"10.1016\/j.bpa.2012.04.003_bib53","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation","volume":"56","author":"Uriel","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1540-8191.2010.01025.x","article-title":"Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD","volume":"25","author":"Stern","year":"2010","journal-title":"J Card Surg"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib55","first-page":"1328","article-title":"Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients","volume":"40","author":"Heilmann","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib56","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejcts.2007.12.047","article-title":"Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease","volume":"33","author":"Geisen","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib57","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1160\/TH09-07-0497","article-title":"Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart","volume":"103","author":"Heilmann","year":"2010","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00134-011-2370-6","article-title":"Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS)","volume":"38","author":"Heilmann","year":"2012","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCHEARTFAILURE.109.877597","article-title":"Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device","volume":"3","author":"Meyer","year":"2010","journal-title":"Circ Heart Fail."},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMp030055","article-title":"Aortic stenosis, von Willebrand factor, and bleeding","volume":"349","author":"Sadler","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib63","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1160\/TH09-06-0391","article-title":"Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis","volume":"103","author":"Panzer","year":"2010","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4065\/mcp.2010.0309","article-title":"Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy","volume":"86","author":"Blackshear","year":"2011","journal-title":"Mayo Clin Proc."},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ageing\/afp019","article-title":"Heyde syndrome: a common diagnosis in older patients with severe aortic stenosis","volume":"38","author":"Massyn","year":"2009","journal-title":"Age Ageing"},{"issue":"Suppl. 3","key":"10.1016\/j.bpa.2012.04.003_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2516.1998.0040s3025.x","article-title":"Characterization of factor VIII\/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis","volume":"4","author":"Metzner","year":"1998","journal-title":"Haemophilia"},{"issue":"Suppl. 5","key":"10.1016\/j.bpa.2012.04.003_bib67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2516.2008.01850.x","article-title":"Haemate P\/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experience","author":"Auerswald","year":"2008","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"9","key":"10.1016\/j.bpa.2012.04.003_bib69","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00101-009-1599-8","article-title":"Therapeutic options for perioperatively acquired platelet dysfunctions","volume":"58","author":"Weber","year":"2009","journal-title":"Anaesthesist"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib70","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1213\/ANE.0b013e3181c92a5c","article-title":"A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery","volume":"110","author":"Weber","year":"2010","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/EJA.0b013e32834050ab","article-title":"Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy","volume":"28","author":"Weber","year":"2011","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1213\/ANE.0b013e318236b16a","article-title":"Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease","volume":"114","author":"Lison","year":"2012","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib73","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/j.thromres.2010.05.028","article-title":"Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study","volume":"126","author":"Ternstr\u00f6m","year":"2010","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2005-872853","article-title":"Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation","volume":"54","author":"G\u00f6dje","year":"2006","journal-title":"Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/ALN.0b013e318194b21e","article-title":"Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding","volume":"110","author":"Korte","year":"2009","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib76","first-page":"85","article-title":"XIII in perioperative coagulation management","volume":"24","author":"Korte","year":"2010","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib77","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/ALN.0b013e3181942c65","article-title":"Excessive perioperative bleeding: are fibrin monomers and factor XIII the missing link?","volume":"110","author":"Spahn","year":"2009","journal-title":"Anesthesiology"},{"issue":"3 Suppl. 1","key":"10.1016\/j.bpa.2012.04.003_bib78","first-page":"S64","article-title":"Coagulation management during liver transplantation","volume":"26","author":"G\u00f6rlinger","year":"2006","journal-title":"H\u00e4mostaseologie"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib79","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00101-008-1360-8","article-title":"Thromboelastometric detection of factor XIII deficiency","volume":"57","author":"Weber","year":"2008","journal-title":"Anaesthesist"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib80","first-page":"385","article-title":"In\u00a0vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM)","volume":"104","author":"Theusinger","year":"2010","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib81","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1213\/ANE.0b013e31823b6683","article-title":"Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood","volume":"114","author":"Dirkmann","year":"2012","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib82","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1525-1594.2000.06493.x","article-title":"Glycoprotein IIb\/IIIa receptor inhibitor attenuates platelet aggregation induced by thromboxane A2 during in\u00a0vitro nonpulsatile ventricular assist circulation","volume":"24","author":"Yomo","year":"2000","journal-title":"Artif Organs"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib83","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00002480-200105000-00025","article-title":"Tirofiban administration attenuates platelet and platelet-neutrophil conjugation but not neutrophil degranulation during in\u00a0vitro VAD circulation","volume":"47","author":"King","year":"2001","journal-title":"ASAIO J"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib84","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1160\/TH05-06-0420","article-title":"Thromboelastography for the monitoring of lipopolysaccharide induced activation of coagulation","volume":"95","author":"Zacharowski","year":"2006","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib85","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1525-1594.2007.00351.x","article-title":"Leukocyte-platelet aggregates and monocyte tissue factor expression in bovines implanted with ventricular assist devices","volume":"31","author":"Snyder","year":"2007","journal-title":"Artif Organs"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1213\/ane.0b013e3181a27cfb","article-title":"Thiopental inhibits lipopolysaccharide-induced tissue factor expression","volume":"109","author":"Hartmann","year":"2009","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib87","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2008.000042","article-title":"Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins","volume":"94","author":"Semeraro","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib88","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SHK.0b013e318204bff6","article-title":"Comparison of thromboelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study","volume":"35","author":"Adamzik","year":"2011","journal-title":"Shock"},{"issue":"3\u20134","key":"10.1016\/j.bpa.2012.04.003_bib89","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2119\/molmed.2010.00159","article-title":"Thromboelastometry (TEM) findings in disseminated intravascular coagulation in a pig model of endotoxinemia","volume":"17","author":"Sch\u00f6chl","year":"2011","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MBC.0b013e32831be9ad","article-title":"Endotoxinemia-induced changes in coagulation as measured by rotation thromboelastometry technique and conventional laboratory tests: results of a pilot study on pigs","volume":"20","author":"Velik-Salchner","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib91","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0003-4975(03)01034-8","article-title":"Coagulation monitoring and management of anticoagulation during cardiac assist device support","volume":"76","author":"Fries","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.bpa.2012.04.003_bib92","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.healun.2006.03.013","article-title":"An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent","volume":"25","author":"Studer","year":"2006","journal-title":"J Heart Lung Transplant"},{"issue":"20","key":"10.1016\/j.bpa.2012.04.003_bib93","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMe0706859","article-title":"Intensifying platelet inhibition\u2013navigating between Scylla and Charybdis","volume":"357","author":"Bhatt","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib94","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10047-010-0527-7","article-title":"Safety and effectiveness of low dosing of double antiplatelet therapy during long-term left ventricular support with the INCOR system","volume":"13","author":"Attisani","year":"2010","journal-title":"J Artif Organs"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib95","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1213\/01.ANE.0000155290.86795.12","article-title":"Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction","volume":"100","author":"McCrath","year":"2005","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib96","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0267659108094738","article-title":"Whole blood hypercoagulability despite anticoagulation during mechanical cardiac assist","volume":"23","author":"Niemi","year":"2008","journal-title":"Perfusion"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib97","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.surg.2009.06.054","article-title":"Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients","volume":"146","author":"Kashuk","year":"2009","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib98","first-page":"1403","article-title":"The role of rotation thromboelastometry in early prediction of massive transfusion","volume":"69","author":"Leemann","year":"2010","journal-title":"J Trauma"},{"issue":"12","key":"10.1016\/j.bpa.2012.04.003_bib99","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1097\/CCM.0b013e3182281af5","article-title":"Functional definition and characterization of acute traumatic coagulopathy","volume":"39","author":"Davenport","year":"2011","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib100","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/ALN.0b013e31823497dd","article-title":"First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study","volume":"115","author":"G\u00f6rlinger","year":"2011","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib101","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/cc10539","article-title":"FIBTEM provides early prediction of massive transfusion in trauma","volume":"15","author":"Sch\u00f6chl","year":"2011","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib102","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.surg.2011.06.023","article-title":"Viscoelastic clot strength predicts coagulation-related mortality within 15 minutes","volume":"151","author":"Pezold","year":"2012","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/039139889702000107","article-title":"Global and extended coagulation monitoring during extracorporeal lung assist with heparin-coated systems in ARDS patients","volume":"20","author":"Gerlach","year":"1997","journal-title":"Int J Artif Organs"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib104","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ncpcardio1441","article-title":"Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices","volume":"6","author":"Majeed","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib105","doi-asserted-by":"crossref","first-page":"R178","DOI":"10.1186\/cc9284","article-title":"Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults","volume":"14","author":"Adamzik","year":"2010","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib106","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/B:THRO.0000024052.79415.62","article-title":"4G\/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study","volume":"16","author":"Burzotta","year":"2003","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib107","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/ALN.0b013e318167aecc","article-title":"Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene","volume":"108","author":"Iribarren","year":"2008","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib108","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/EJA.0b013e3283240412","article-title":"PAI-1 gene: pharmacogenetic association of 4G\/4G genotype with bleeding after cardiac surgery \u2013 pilot study","volume":"26","author":"Sirgo","year":"2009","journal-title":"Eur J Anaesthesiol"},{"issue":"7","key":"10.1016\/j.bpa.2012.04.003_bib109","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00134-007-0649-4","article-title":"Insertion\/deletion polymorphism in the promoter of NF-\u03baB1 influences severity but not mortality of acute respiratory distress syndrome","volume":"33","author":"Adamzik","year":"2007","journal-title":"Intensive Care Med"},{"issue":"7\/8","key":"10.1016\/j.bpa.2012.04.003_bib110","first-page":"365","article-title":"Der Insertions-Deletions polymorphismus NF-\u03baB1 (-94ins\/delATTG) im Promotor von NF-\u03baB1 beeinflusst seine Expression sowie die LPS-induzierte Tu\u00edssue-Factor-Aktivit\u00e4t","volume":"49","author":"Adamzik","year":"2008","journal-title":"An\u00e4sth Intensivmed"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib111","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.STR.0000064326.65899.AC","article-title":"Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study","volume":"34","author":"Grau","year":"2003","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib112","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.bpa.2012.04.003_bib113","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0735-1097(03)01000-3","article-title":"Determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"42","author":"Topol","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"3 Suppl. 1","key":"10.1016\/j.bpa.2012.04.003_bib114","first-page":"S20","article-title":"Possibilities and limitations of thromboelastometry\/-graphy","volume":"26","author":"Lang","year":"2006","journal-title":"H\u00e4mostaseologie"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib115","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3174\/ajnr.A0917","article-title":"Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting","volume":"29","author":"M\u00fcller-Schunk","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1016\/j.bpa.2012.04.003_bib116","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation","volume":"29","author":"Price","year":"2008","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib117","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1160\/TH07-07-0478","article-title":"Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment","volume":"99","author":"Sibbing","year":"2008","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.bpa.2012.04.003_bib118","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"Sibbing","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib119","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ahj.2010.06.004","article-title":"Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis","volume":"160","author":"Aradi","year":"2010","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH09-05-0284","article-title":"Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting","volume":"103","author":"Sibbing","year":"2010","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib121","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1538-7836.2009.03709.x","article-title":"Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement","volume":"8","author":"Sibbing","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib122","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2010.03.048","article-title":"Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window","volume":"56","author":"Sibbing","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib123","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1538-7836.2009.03699.x","article-title":"Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay","volume":"8","author":"Siller-Matula","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib124","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MBC.0b013e328332dbd4","article-title":"Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry","volume":"21","author":"von Beckerath","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"19","key":"10.1016\/j.bpa.2012.04.003_bib125","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","article-title":"Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data","volume":"58","author":"Brar","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.bpa.2012.04.003_bib126","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.amjcard.2010.11.025","volume":"107","author":"Patti","year":"2011","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.bpa.2012.04.003_bib127","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: impact on thrombosis and safety (GRAVITAS) trial","volume":"124","author":"Price","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bpa.2012.04.003_bib128","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-012-0684-z","article-title":"Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention","author":"Hazarbasanov","year":"2012","journal-title":"J Thromb Thrombolysis"},{"issue":"22","key":"10.1016\/j.bpa.2012.04.003_bib129","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jacc.2007.03.019","article-title":"Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention","volume":"49","author":"Mahmud","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.bpa.2012.04.003_bib130","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jacc.2008.05.054","article-title":"Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel","volume":"52","author":"Ang","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.bpa.2012.04.003_bib131","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/j.1538-7836.2009.03599.x","article-title":"Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control","volume":"7","author":"Gaborit","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib132","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1160\/TH10-05-0266","article-title":"Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment","volume":"104","author":"Bernlochner","year":"2010","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.bpa.2012.04.003_bib133","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1253\/circj.72.1165","article-title":"Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel","volume":"72","author":"Malek","year":"2008","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib134","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators. Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib136","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1160\/TH08-12-0808","article-title":"Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel","volume":"101","author":"Sibbing","year":"2009","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib137","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1160\/TH09-06-0367","article-title":"The influence of variation in the P2Y12 receptor gene on in\u00a0vitro platelet inhibition with the direct P2Y12 antagonist cangrelor","volume":"103","author":"Bouman","year":"2010","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib138","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/dmdi.2011.002","article-title":"Clopidogrel pharmacogenetics: metabolism and drug interactions","volume":"26","author":"Close","year":"2011","journal-title":"Drug Metabol Drug Interact"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib139","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1160\/TH10-11-0715","article-title":"Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy","volume":"105","author":"Fernando","year":"2011","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3909\/ricm0590","article-title":"The influence of CYP2C19 polymorphisms on the pharmacokinetics, pharmacodynamics, and clinical effectiveness of P2Y(12) inhibitors","volume":"12","author":"Price","year":"2011","journal-title":"Rev Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib141","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1373\/clinchem.2005.059535","article-title":"Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor","volume":"52","author":"Ivandic","year":"2006","journal-title":"Clin Chem"},{"issue":"22","key":"10.1016\/j.bpa.2012.04.003_bib142","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jacc.2010.02.031","article-title":"Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement","volume":"55","author":"Hochholzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib143","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2012.04639.x","article-title":"Phenotyping versus genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study","volume":"10","author":"Siller-Matula","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib144","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.athoracsur.2007.10.039","article-title":"Hemostasis management in pediatric mechanical circulatory support","volume":"85","author":"Seibel","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/2047-783X-15-5-214","article-title":"Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate)","volume":"15","author":"Hanke","year":"2010","journal-title":"Eur J Med Res."},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib146","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2011.08.019","article-title":"Platelet aggregation is dependent on platelet count in patients with coronary artery disease","volume":"129","author":"W\u00fcrtz","year":"2012","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib147","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09537100600944277","article-title":"Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals","volume":"18","author":"Seyfert","year":"2007","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib148","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MBC.0b013e3283424911","article-title":"The influence of platelets, plasma and red blood cells on functional haemostatic assays","volume":"22","author":"Bochsen","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib149","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00395-009-0073-8","article-title":"Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes","volume":"105","author":"Diehl","year":"2010","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib150","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1053-2498(00)00088-7","article-title":"Changes in platelet activation associated with left ventricular assist system placement","volume":"19","author":"Matsubayashi","year":"2000","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib151","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/01.MAT.0000136515.97686.A2","article-title":"Extensive coagulation monitoring in patients after implantation of the MicroMed Debakey continuous flow axial pump","volume":"50","author":"Bonaros","year":"2004","journal-title":"ASAIO J"},{"issue":"14","key":"10.1016\/j.bpa.2012.04.003_bib152","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 45","key":"10.1016\/j.bpa.2012.04.003_bib153","first-page":"89","article-title":"Anticoagulation monitoring with thromboelastometry (ROTEM) and impedance aggregometry (Multiplate) I a patient with an INCOR vertricular assist device","volume":"26","author":"G\u00f6rlinger","year":"2009","journal-title":"Eur J Anaesth"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib154","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ahj.2011.08.021","article-title":"Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research","volume":"162","author":"Chin","year":"2011","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib155","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ejcts.2004.12.010","article-title":"Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?","volume":"27","author":"Zimmermann","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"issue":"8","key":"10.1016\/j.bpa.2012.04.003_bib156","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3109\/09537104.2010.502981","article-title":"Individual variability of response and non-response to acetyl salicylic acid after cardiac surgery","volume":"21","author":"B\u00f6rgermann","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.bpa.2012.04.003_bib157","article-title":"Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy","author":"Petricevic","year":"2011","journal-title":"Heart Vessels"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib158","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2011.00930.x","article-title":"Platelet activation in obesity and metabolic syndrome","volume":"13","author":"Santilli","year":"2012","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib159","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/09537100902780650","article-title":"The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery","volume":"20","author":"Bach","year":"2009","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11239-010-0457-5","article-title":"Poor response to clopidogrel: current and future options for its management","volume":"30","author":"Campo","year":"2010","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib161","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1160\/TH07-09-0575","article-title":"The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration","volume":"99","author":"Jakubowski","year":"2008","journal-title":"Thromb Haemost"},{"issue":"25","key":"10.1016\/j.bpa.2012.04.003_bib162","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/CIRCULATIONAHA.108.833236","volume":"119","author":"Valgimigli","year":"2009","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.bpa.2012.04.003_bib163","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jacc.2010.03.103","volume":"56","author":"Campo","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib164","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.athoracsur.2006.05.077","article-title":"Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients","volume":"83","author":"Koster","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib165","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.athoracsur.2007.03.049","article-title":"Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients","volume":"84","author":"Schroder","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib166","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00101-007-1297-3","article-title":"Patient with heparin-induced thrombocytopenia type II and implanted left ventricular assist device","volume":"57","author":"Lutz","year":"2008","journal-title":"Anaesthesist"},{"issue":"4","key":"10.1016\/j.bpa.2012.04.003_bib167","first-page":"329","article-title":"Lung Transplant Group TM. Extracorporeal membrane oxygenation bridging to lung transplant complicated by heparin-induced thrombocytopenia","volume":"8","author":"Dolch","year":"2010","journal-title":"Exp Clin Transplant"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib168","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1051\/ject\/201143005","article-title":"Heparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literature","volume":"43","author":"Pollak","year":"2011","journal-title":"J Extra Corpor Technol"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib169","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib170","doi-asserted-by":"crossref","DOI":"10.1542\/peds.109.6.e89","article-title":"Multicenter analysis of platelet transfusion usage among neonates on extracorporeal membrane oxygenation","volume":"109","author":"Chevuru","year":"2002","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib171","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bpa.2012.04.003_bib172","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/asheducation-2010.1.135","article-title":"Thrombocytopenia in the intensive care unit patient","volume":"2010","author":"Greinacher","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib173","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ejcts.2009.12.023","article-title":"Perioperative thrombocytopenia in cardiac surgical patients \u2013 incidence of heparin-induced thrombocytopenia, morbidities and mortality","volume":"37","author":"Thielmann","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib174","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.hrtlng.2009.07.005","article-title":"Thrombocytopenia and outcome in critically ill patients with bloodstream infection","volume":"39","author":"Vandijck","year":"2010","journal-title":"Heart Lung"},{"issue":"6 Suppl.","key":"10.1016\/j.bpa.2012.04.003_bib175","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American college of chest physicians evidence-based clinical practice guidelines (8th Edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib176","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0037-1617144","article-title":"Heparin-induced thrombocytopenia","volume":"30","author":"Greinacher","year":"2010","journal-title":"H\u00e4mostaseologie"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib177","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00002480-200005000-00015","article-title":"Prevalence and persistence of heparin\/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices","volume":"46","author":"Koster","year":"2000","journal-title":"ASAIO J"},{"issue":"6","key":"10.1016\/j.bpa.2012.04.003_bib178","first-page":"697","article-title":"Heparin induced thrombocytopenia in patients with ventricular assistance device bridge-to-transplantation. A case series","volume":"56","author":"Nocera","year":"2008","journal-title":"Minerva Cardioangiol"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib179","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.athoracsur.2008.10.060","article-title":"Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?","volume":"87","author":"Warkentin","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.bpa.2012.04.003_bib180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1538-7836.2009.03626.x","article-title":"Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive","volume":"8","author":"Selleng","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.bpa.2012.04.003_bib181","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1016\/j.thromres.2009.12.001","article-title":"Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies","volume":"125","author":"Morel-Kopp","year":"2010","journal-title":"Thromb Res"},{"issue":"12","key":"10.1016\/j.bpa.2012.04.003_bib182","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1592\/phco.2005.25.12.1736","article-title":"Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia","volume":"25","author":"Kiser","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib183","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00002018-200932030-00003","article-title":"Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia","volume":"32","author":"Hursting","year":"2009","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib184","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1213\/ane.0b013e31815edb52","article-title":"Acute left atrial thrombus after recombinant factor VIIa administration during left ventricular assist device implantation in a patient with heparin-induced thrombocytopenia","volume":"106","author":"Apostolidou","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2012.04.003_bib185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1749-8090-2-32","article-title":"Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant","volume":"2","author":"Gandhi","year":"2007","journal-title":"J Cardiothorac Surg"},{"issue":"8","key":"10.1016\/j.bpa.2012.04.003_bib186","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.healun.2009.04.028","article-title":"High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII","volume":"28","author":"Bruckner","year":"2009","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib187","first-page":"228","article-title":"Pulmonary microthrombi during left ventricular assist device implantation","volume":"32","author":"Gregoric","year":"2005","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.bpa.2012.04.003_bib188","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1537-2995.2004.03322.x","article-title":"Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes","volume":"44","author":"Spiess","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.bpa.2012.04.003_bib189","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1097\/01.CCM.0000186745.53059.F0","article-title":"Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy","volume":"33","author":"Dara","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bpa.2012.04.003_bib190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1378\/chest.127.1.295","article-title":"Anemia, allogenic blood transfusion, and immunomodulation in the critically ill","volume":"127","author":"Raghavan","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.bpa.2012.04.003_bib191","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jamcollsurg.2005.08.028","article-title":"Transfusion increases the risk of postoperative infection after cardiovascular surgery","volume":"202","author":"Banbury","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.bpa.2012.04.003_bib192","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1378\/chest.06-3048","article-title":"Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients","volume":"131","author":"Khan","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.bpa.2012.04.003_bib193","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","article-title":"Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery","volume":"116","author":"Murphy","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bpa.2012.04.003_bib194","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1097\/CCM.0b013e3181844677","article-title":"Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature","volume":"36","author":"Marik","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bpa.2012.04.003_bib195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/asheducation-2007.1.179","article-title":"The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy","author":"Stanworth","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bpa.2012.04.003_bib196","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/CCM.0b013e318168f89d","article-title":"Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection","volume":"36","author":"Sarani","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bpa.2012.04.003_bib197","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1423-0410.2009.01167.x","article-title":"Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma","volume":"96","author":"Shanwell","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.bpa.2012.04.003_bib198","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tracli.2009.04.008","article-title":"Pulmonary complications of transfusion (TACO-TRALI)","volume":"16","author":"Renaudier","year":"2009","journal-title":"Transfus Clin Biol"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib199","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000337723","article-title":"Thromboelastometry based early goal-directed coagulation management reduces blood transfusion requirements, adverse events, and costs in acute type A aortic dissection: A pilot study","volume":"39","author":"Hanke","year":"2012","journal-title":"Transfus Med Hemother"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib200","first-page":"145","article-title":"Algorithms for transfusion and coagulation management in massive haemorrhage","volume":"52","author":"G\u00f6rlinger","year":"2011","journal-title":"An\u00e4sth Intensivemed"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib201","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000337186","article-title":"Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy","volume":"39","author":"G\u00f6rlinger","year":"2012","journal-title":"Transfus Med Hemother"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib202","first-page":"360","article-title":"Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates","volume":"81","author":"Hiippala","year":"1995","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2012.04.003_bib203","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/ALN.0b013e3181f22b5a","article-title":"Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution","volume":"113","author":"Bolliger","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2012.04.003_bib204","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1532\/HSF98.20071065","article-title":"Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery","volume":"10","author":"Ucar","year":"2007","journal-title":"Heart Surg Forum"},{"key":"10.1016\/j.bpa.2012.04.003_bib205","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1537-2995.2008.01827.x","article-title":"Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study","volume":"48","author":"Karlsson","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.bpa.2012.04.003_bib206","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MBC.0b013e3282f3f9d4","article-title":"The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass","volume":"19","author":"Reinh\u00f6fer","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.bpa.2012.04.003_bib207","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1160\/TH08-09-0587","article-title":"Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study","volume":"102","author":"Karlsson","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bpa.2012.04.003_bib208","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/bja\/aep089","article-title":"Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study","volume":"102","author":"Rahe-Meyer","year":"2009","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.bpa.2012.04.003_bib209","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jtcvs.2008.11.065","article-title":"Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery","volume":"138","author":"Rahe-Meyer","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bpa.2012.04.003_bib210","doi-asserted-by":"crossref","DOI":"10.1186\/cc10488","article-title":"Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review","volume":"15","author":"Kozek-Langenecker","year":"2011","journal-title":"Critical Care"},{"key":"10.1016\/j.bpa.2012.04.003_bib211","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1160\/TH07-05-0367","article-title":"Pharmacokinetics of Beriplex P\/N prothrombin complex concentrate in healthy volunteers","volume":"98","author":"Ostermann","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bpa.2012.04.003_bib212","doi-asserted-by":"crossref","DOI":"10.1186\/cc6987","article-title":"Prothrombin complex concentrate (Beriplex P\/N) in severe bleeding: experience in a large tertiary hospital","volume":"12","author":"Bruce","year":"2008","journal-title":"Critical Care"},{"key":"10.1016\/j.bpa.2012.04.003_bib213","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2008.02904.x","article-title":"Prothrombin complex concentrate (Beriplex_ P\/N) for emergency anticoagulation reversal: a prospective multinational clinical trial","volume":"6","author":"Pabinger","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 2","key":"10.1016\/j.bpa.2012.04.003_bib214","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0049-3848(08)70005-7","article-title":"Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate","volume":"122","author":"Pabinger-Fasching","year":"2008","journal-title":"Thromb Res"},{"issue":"Suppl. 2","key":"10.1016\/j.bpa.2012.04.003_bib215","first-page":"863","article-title":"Efficacy and long-term safety of a pasteurised and nanofiltrated prothrombin complex concentrate (Beriplex\u00ae P\/N)","volume":"7","author":"Hanke","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bpa.2012.04.003_bib216","doi-asserted-by":"crossref","DOI":"10.1186\/cc8186","article-title":"Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding","volume":"13","author":"Schick","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.bpa.2012.04.003_bib217","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/cc9311","article-title":"Clinical review: prothrombin complex concentrates \u2013 evaluation of safety and thrombogenicity","volume":"15","author":"S\u00f8rensen","year":"2011","journal-title":"Critical Care"},{"issue":"2","key":"10.1016\/j.bpa.2012.04.003_bib218","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.thromres.2011.07.024","article-title":"Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy","volume":"129","author":"Majeed","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.bpa.2012.04.003_bib219","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1537-2995.2008.02080.x","article-title":"Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose","volume":"49","author":"Holland","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.bpa.2012.04.003_bib220","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1742-1241.2008.01859.x","article-title":"Biochemical comparison of seven commercially available prothrombin complex concentrates","volume":"62","author":"Kalina","year":"2008","journal-title":"Int J Clin Pract"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689612000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689612000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:16:40Z","timestamp":1776410200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689612000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":220,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1521689612000316"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2012.04.003","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation management in patients undergoing mechanical circulatory support","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2012.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}